Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH) (CLEVAS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02011321|
Recruitment Status : Unknown
Verified December 2013 by Panayiotis Varelas, Henry Ford Health System.
Recruitment status was: Not yet recruiting
First Posted : December 13, 2013
Last Update Posted : December 13, 2013
Henry Ford Health System
Information provided by (Responsible Party):
Panayiotis Varelas, Henry Ford Health System
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||March 2015|
|Estimated Study Completion Date :||September 2015|
Varelas PN, Abdelhak T, Corry JJ, James E, Rehman MF, Schultz L, Mays-Wilson K, Mitsias P. Clevidipine for acute hypertension in patients with subarachnoid hemorrhage: a pilot study. Int J Neurosci. 2014 Mar;124(3):192-8. doi: 10.3109/00207454.2013.836703. Epub 2013 Sep 24.